Biologics Spine Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration byJosh SandbergJuly 29, 2025
Spine Top Stories Drs. Todd H. Lanman and Jason M. Cuellar Become First Surgeons in the U.S. to Perform 3-Level ADR With Prodisc® C Vivo byChris StewartOctober 19, 2022
Biologics Spine DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa byChris StewartOctober 5, 2022
Neuro Spine ADR Spinal Restoration Center Opens Up 2-Level prodisc® and 1-Level Synergy Disc® Clinical Trials in Los Angeles byJosh SandbergMay 25, 2021
Biologics Spine DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone byJosh SandbergApril 27, 2021
Regulatory Spine NuVasive Receives FDA Clearance for Expanded Multi-Level Use of CoRoent Small Interlock™ System for the Cervical Spine byJosh SandbergNovember 21, 2019
Biologics SpinalCyte Announces Publication Supporting the Therapeutic Effects of Fibroblast Cell Therapy in Disc Degeneration and Inflammation in The Spine Journal byJosh SandbergOctober 11, 2018
Spine 5 things to know on disc degeneration after scoliosis spinal fusion byJosh SandbergNovember 2, 2015
Spine 5 things to know on disc degeneration after scoliosis spinal fusion byJosh SandbergOctober 27, 2015
Spine Spinal fusion after 10 years: 5 key notes on adjacent segment disease byJosh SandbergJuly 17, 2015
